Evidence map›Paper›PMID 39133894›Full record

ArticleACS nano2024

Time-Resolved Inspection of Ionizable Lipid-Facilitated Lipid Nanoparticle Disintegration and Cargo Release at an Early Endosomal Membrane Mimic.

Nima Aliakbarinodehi, Simon Niederkofler, Gustav Emilsson, Petteri Parkkila, Erik Olsén, Yujia Jing, Mattias Sjöberg, Björn Agnarsson, Lennart Lindfors, Fredrik Höök

Abstract read
In one paragraph

Article in ACS nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Multiparametric functional characterization of individual lipid nanoparticles using surface-sensitive light-scattering microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nima AliakbarinodehiDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0002-8814-4695
Simon NiederkoflerDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0009-0006-6893-1444
Gustav EmilssonAdvanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden.ORCID 0000-0002-5030-3953
Petteri ParkkilaDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0002-2717-0232
Erik OlsénDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0002-4002-0917
Yujia JingAdvanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden.ORCID 0000-0002-6060-5197
Mattias SjöbergDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0003-3753-2564
Björn AgnarssonDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0003-3364-7196
Lennart LindforsAdvanced Drug Delivery, Pharmaceutical Sciences, AstraZeneca R&D, Mölndal 43181, Sweden.ORCID 0000-0002-6711-0605
Fredrik HöökDepartment of Physics, Division of Nano and Biophysics, Chalmers University of Technology, Göteborg 41296, Sweden.ORCID 0000-0003-1994-5015

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in lipid nanoparticle (LNP) design have contributed notably to the emergence of the current clinically approved mRNA-based vaccines and are of high relevance for delivering mRNA to combat diseases where therapeutic alternatives are sparse. LNP-assisted mRNA delivery utilizes ionizable lipid-mediated cargo translocation across the endosomal membrane driven by the acidification of the endosomal environment. However, this process occurs at a low efficiency, a few percent at the best. Utilizing surface-sensitive fluorescence microscopy with a single LNP and mRNA resolution, we have investigated pH-controlled interactions between individual LNPs and a planar anionic supported lipid bilayer (SLB) formed on nanoporous silica, mimicking the electrostatic conditions of the early endosomal membrane. For LNPs with an average diameter of 140 nm, fusion with the anionic SLB preferentially occurred when the pH was reduced from 6.6 to 6.0. Furthermore, there was a delay in the onset of LNP fusion after the pH drop, and upon fusion, a significant fraction (>70%) of mRNA was released into the acidic solution representing the endosomal lumen, while a fraction of mRNA remained bound to the SLB even after reversing the pH to neutral cytosolic conditions. Finally, a comparison of the fusion efficiency of two LNP formulations with different surface concentrations of gel-forming lipids correlated with differences in the protein translation efficiency previously observed in human primary cell transfection studies. Together, these findings emphasize the relevance of biophysical investigations of ionizable lipid-containing LNP-assisted mRNA delivery mechanisms while potentially also offering means to optimize the design of LNPs with enhanced endosomal escape capabilities.

Indexed as

EndosomesLipidsNanoparticlesHumansHydrogen-Ion ConcentrationLipid BilayersLiposomesRNA, MessengerSilicon DioxideLipid BilayersLipid NanoparticlesLipidsLiposomesRNA, MessengerSilicon Dioxideearly endosomal membrane mimicendosomal escapelipid nanoparticle fusionlipid nanoparticle (LNP)mRNA delivery

Identifiers

PMID39133894
PMCPMC11363135

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.